WINNIPEG, MANITOBA--(Marketwire - November 13, 2007) - Kane Biotech Inc. (TSX VENTURE: KNE), a biotechnology company engaged in the development of products that prevent and disperse bacterial biofilms, is pleased to announce the issuance of Patent No. 7,294,497 entitled “Compositions and Methods for Enzymatic Detachment of Bacterial Biofilms”, by the US Patent and Trademark Office. This patent protects DispersinB™, the Company’s core technology, and its use in treating infections caused by biofilms. DispersinB™ can be used in human, animal, plant and industrial applications.
